Study details
Enrolling now
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
University of Colorado, Denver
NCT IDNCT06349577ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,100
Study length
about 3.5 years
Ages
18–85
Locations
1 site in CO
What this study is about
This trial is testing whether pulsatile blood flow during cardiopulmonary bypass can reduce acute kidney injury after cardiac surgery. Investigators will also evaluate the safety and impact of pulsatile flow on clinical outcomes compared to non-pulsatile flow during cardiopulmonary bypass.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Non-pulsatile blood flow
- 2.Pulsatile blood flow
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: 30-day mortality
Body systems
Renal